Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000206348 | SCV000261855 | benign | Adams-Oliver syndrome 5 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000769606 | SCV000319407 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-01-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000434406 | SCV000528006 | benign | not specified | 2016-10-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769606 | SCV000901003 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-03-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000206348 | SCV002555053 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270017 | SCV002555055 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500659 | SCV002809073 | benign | Aortic valve disease 1; Adams-Oliver syndrome 5 | 2021-07-08 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000434406 | SCV004029531 | benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003422112 | SCV004162055 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | NOTCH1: BP4, BP7, BS1, BS2 |
ARUP Laboratories, |
RCV003422112 | SCV004564629 | benign | not provided | 2024-10-28 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV003422112 | SCV005323791 | benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000434406 | SCV001800782 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000434406 | SCV001807686 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000434406 | SCV001921712 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000434406 | SCV001959030 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000434406 | SCV001964679 | benign | not specified | no assertion criteria provided | clinical testing |